Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Proxy Today?

Taken from the Novemer 12, 2009 news release:

Further details pertaining to the shareholder meeting will become available in PTSC's proxy statement expected to be filed with the Securities and Exchange Commission on or about December 7, 2009.

Share
New Message
Please login to post a reply